Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:20940625rdf:typepubmed:Citationlld:pubmed
pubmed-article:20940625lifeskim:mentionsumls-concept:C0006901lld:lifeskim
pubmed-article:20940625lifeskim:mentionsumls-concept:C0085220lld:lifeskim
pubmed-article:20940625lifeskim:mentionsumls-concept:C1521970lld:lifeskim
pubmed-article:20940625pubmed:issue11lld:pubmed
pubmed-article:20940625pubmed:dateCreated2010-10-27lld:pubmed
pubmed-article:20940625pubmed:abstractTextCerebral amyloid angiopathy (CAA) affects brain parenchymal and leptomeningeal arteries and arterioles but sometimes involves capillaries (capCAA) with spread of the amyloid into the surrounding neuropil, that is, dyshoric changes. We determined the relationship between capCAA and larger vessel CAA, ? amyloid (A?) plaques, neurofibrillary changes, inflammation, and apolipoprotein E (APOE) in 22 cases of dyshoric capCAA using immunohistochemistry. The dyshoric changes contained predominantly A?1-40, whereas dense bulblike deposits adjacent to the capillary wall contained mostly A?1-42. There was an inverse local correlation between A? plaque load and capCAA severity (p = 0.01), suggesting that A? transport between the neuropil and the circulation may be mechanistically involved. Deposits of hyperphosphorylated tau and ubiquitin and clusters of activated microglia, resembling the changes around A? plaques, were found around capCAA but were absent around larger vessel CAA. In 14 cases for which APOE genotype was available, there was a high APOE-?4 allele frequency (54%; 43% homozygous). The severity of CapCAA increased with the number of ?4-alleles; and APOE4 seemed to colocalize with capCAA by immunohistochemistry. These results suggest that capCAA is pathologically and possibly pathogenetically distinct from larger vessel CAA, and that it is associated with a high APOE-?4 allele frequency.lld:pubmed
pubmed-article:20940625pubmed:languageenglld:pubmed
pubmed-article:20940625pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20940625pubmed:citationSubsetIMlld:pubmed
pubmed-article:20940625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20940625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20940625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20940625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20940625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20940625pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:20940625pubmed:statusMEDLINElld:pubmed
pubmed-article:20940625pubmed:monthNovlld:pubmed
pubmed-article:20940625pubmed:issn0022-3069lld:pubmed
pubmed-article:20940625pubmed:authorpubmed-author:EikelenboomPi...lld:pubmed
pubmed-article:20940625pubmed:authorpubmed-author:ThalDietmar...lld:pubmed
pubmed-article:20940625pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:20940625pubmed:authorpubmed-author:de...lld:pubmed
pubmed-article:20940625pubmed:authorpubmed-author:RozemullerAnn...lld:pubmed
pubmed-article:20940625pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:20940625pubmed:authorpubmed-author:van...lld:pubmed
pubmed-article:20940625pubmed:authorpubmed-author:HoozemansJero...lld:pubmed
pubmed-article:20940625pubmed:authorpubmed-author:RichardEdoElld:pubmed
pubmed-article:20940625pubmed:authorpubmed-author:CarranoAnnaAlld:pubmed
pubmed-article:20940625pubmed:authorpubmed-author:EurelingsLisa...lld:pubmed
pubmed-article:20940625pubmed:issnTypePrintlld:pubmed
pubmed-article:20940625pubmed:volume69lld:pubmed
pubmed-article:20940625pubmed:ownerNLMlld:pubmed
pubmed-article:20940625pubmed:authorsCompleteYlld:pubmed
pubmed-article:20940625pubmed:pagination1158-67lld:pubmed
pubmed-article:20940625pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:20940625pubmed:meshHeadingpubmed-meshheading:20940625...lld:pubmed
pubmed-article:20940625pubmed:meshHeadingpubmed-meshheading:20940625...lld:pubmed
pubmed-article:20940625pubmed:meshHeadingpubmed-meshheading:20940625...lld:pubmed
pubmed-article:20940625pubmed:meshHeadingpubmed-meshheading:20940625...lld:pubmed
pubmed-article:20940625pubmed:meshHeadingpubmed-meshheading:20940625...lld:pubmed
pubmed-article:20940625pubmed:meshHeadingpubmed-meshheading:20940625...lld:pubmed
pubmed-article:20940625pubmed:meshHeadingpubmed-meshheading:20940625...lld:pubmed
pubmed-article:20940625pubmed:meshHeadingpubmed-meshheading:20940625...lld:pubmed
pubmed-article:20940625pubmed:meshHeadingpubmed-meshheading:20940625...lld:pubmed
pubmed-article:20940625pubmed:meshHeadingpubmed-meshheading:20940625...lld:pubmed
pubmed-article:20940625pubmed:meshHeadingpubmed-meshheading:20940625...lld:pubmed
pubmed-article:20940625pubmed:meshHeadingpubmed-meshheading:20940625...lld:pubmed
pubmed-article:20940625pubmed:meshHeadingpubmed-meshheading:20940625...lld:pubmed
pubmed-article:20940625pubmed:meshHeadingpubmed-meshheading:20940625...lld:pubmed
pubmed-article:20940625pubmed:meshHeadingpubmed-meshheading:20940625...lld:pubmed
pubmed-article:20940625pubmed:year2010lld:pubmed
pubmed-article:20940625pubmed:articleTitleCharacteristics of dyshoric capillary cerebral amyloid angiopathy.lld:pubmed
pubmed-article:20940625pubmed:affiliationDepartment of Neurology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands. e.richard@amc.uva.nllld:pubmed
pubmed-article:20940625pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:20940625pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:348entrezgene:pubmedpubmed-article:20940625lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:20940625lld:entrezgene